Genetic Polymorphisms of CYP2D6 Oxidation in Patients with Inflammatory Bowel Disease

Trzcinski, R.; Skretkowicz, J.; Dziki, A.; Rychlik-Sych, M.; Baranska, M.
April 2010
Digestive Diseases & Sciences;Apr2010, Vol. 55 Issue 4, p1037
Academic Journal
Inflammatory bowel disease (IBD) consists of ulcerative colitis and Crohn’s disease, both of which are associated with increased colorectal cancer risk. The relationship between genetically determined polymorphic metabolism of exogenous substances by oxidation catalyzed by CYP2D6 isoenzyme and susceptibility to cancer has aroused great interest. We determined whether there was an association between susceptibility to inflammatory bowel disease and particularly to CYP2D6 genotypes. The study was carried out in 39 patients with IBD. The control group consisted of 129 healthy volunteers. The CYP2D6 genotypes were analyzed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method with DNA extracted from peripheral blood. Among 39 patients with inflammatory bowel disease, extensive metabolizer (EM) genotype constituted 97.4%. One patient (2.6%) was poor metabolizer with CYP2D6*4/CYP2D6*4 genotype. Results obtained in the inflammatory bowel disease group did not differ significantly from those of the control group. Although the odds ratio for EM metabolizers was about 3.8-fold greater in the group of patients with inflammatory bowel disease, this association was not statistically significant. This data also showed no overall statistically significant association between alleles and incidence risk of inflammatory bowel disease [odds ratio (OR) of 1.36 for CYP2D6*1 allele, 0.83 for CYP2D6*3 allele, and 0.74 for CYP2D6*4 allele]. The present results suggest that EM genotype may be the risk factor of inflammatory bowel disease. Future studies are needed to confirm our assumptions on larger group of patients.


Related Articles

  • rs224136 on Chromosome 10q21.1 and Variants in PHOX2B, NCF4, and FAM92B Are Not Major Genetic Risk Factors for Susceptibility to Crohn's Disease in the German Population. Glas, Jürgen; Seiderer, Julia; Pasciuto, Giulia; Tillack, Cornelia; Diegelmann, Julia; Pfennig, Simone; Konrad, Astrid; Schmechel, Silke; Wetzke, Martin; Török, Helga-Paula; Stallhofer, Johannes; Jürgens, Matthias; Griga, Thomas; Klein, Wolfram; Epplen, Jörg T.; Schiemann, Uwe; Mussack, Thomas; Lohse, Peter; Göke, Burkhard; Ochsenkühn, Thomas // American Journal of Gastroenterology;Mar2009, Vol. 104 Issue 3, p665 

    OBJECTIVES:Recently, a North American genome-wide association study identified three novel gene variants in PHOX2B, NCF4, and FAM92B as well as one single nucleotide polymorphisms (SNP; rs224136) in the intergenic region on chromosome 10q21.1 as being associated with Crohn's disease (CD)....

  • Confirmation of Multiple Crohn's Disease Susceptibility Loci in a Large Dutch—Belgian Cohort. Weersma, Rinse K.; Stokkers, Pieter C. F.; Cleynen, Isabelle; Wolfkamp, Simone C. S.; Henckaerts, Liesbet; Schreiber, Stefan; Dijkstra, Gerard; Franke, Andre; Nolte, Ilja M.; Rutgeerts, Paul; Wijmenga, Cisca; Vermeire, Séverine // American Journal of Gastroenterology;Mar2009, Vol. 104 Issue 3, p630 

    OBJECTIVES:Inflammatory bowel diseases (IBD)—Crohn's disease (CD) and ulcerative colitis (UC)—are chronic gastrointestinal inflammatory disorders with a complex genetic background. A genome-wide association scan by the Wellcome Trust Case Control Consortium (WTCCC) recently...


    The article investigates clinical and functional significance of Vitamin D receptor (VDR) polymorphisms in inflammatory bowel disease. For the study purpose genomic DNA was extracted from 218 inflammatory bowel disease (IBD) patient and also included ulcerative colitis, Crohn's disease (CD) and...

  • The ATG16L1 Gene Variants rs2241879 and rs2241880 (T300A) Are Strongly Associated With Susceptibility to Crohn's Disease in the German Population. Glas, Jürgen; Konrad, Astrid; Schmechel, Silke; Dambacher, Julia; Seiderer, Julia; Schroff, Frieder; Wetzke, Martin; Roeske, Darina; Török, Helga-Paula; Tonenchi, Laurian; Pfennig, Simone; Haller, Dirk; Griga, Thomas; Klein, Wolfram; Epplen, Jörg T.; Folwaczny, Christian; Lohse, Peter; Göke, Burkhard; Ochsenkühn, Thomas; Mussack, Thomas // American Journal of Gastroenterology;Mar2008, Vol. 103 Issue 3, p682 

    OBJECTIVES: We analyzed ATG16L1, a recently identified Crohn's disease (CD) susceptibility gene, in a large cohort with inflammatory bowel disease (IBD) including potential interactions with other IBD genes as well as factors regulating its gene expression. METHODS: Genomic DNA from 2,890...

  • A Population-Based Case-Control Study of CARD15 and Other Risk Factors in Crohn's Disease and Ulcerative Colitis. Brant, Steven R.; Ming-Hsi Wang; Rawsthorne, Patricia; Sargent, Michael; Datta, Lisa Wu; Nouvet, Franklin; Yin Yao Shugart; Bernstein, Charles N. // American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p313 

    OBJECTIVES: Multiple established Crohn's disease (CD) and ulcerative colitis (UC) risk factors including family history, tobacco use, Jewish ethnicity, urban residency, and CARD15/NOD2 mutations have been evaluated singly and in hospital-based observational studies. The goal of this study was to...

  • Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Sashio, Hiroko; Tamura, Kazuo; Ito, Reiko; Yamamoto, Yoshihiro; Bamba, Hiroko; Kosaka, Tadashi; Fukui, Shin; Sawada, Koji; Fukuda, Yoshihiro; Tamura, Kazutami; Satomi, Masamichi; Shimoyama, Takashi; Furuyama, Jun-ichi // Immunogenetics;Mar2002, Vol. 53 Issue 12, p1020 

    The importance of tumor necrosis factor (TNF)-alpha and the TNF receptor gene polymorphisms in the etipathogenesis of inflammatory bowel disease (IBD) has not been elucidated. DNA from peripheral blood samples was obtained from 124 patients with Crohn's disease (CD), 106 patients with ulcerative...

  • Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand Caucasian population: a case-control study. Huebner, Claudia; Ferguson, Lynnette R.; Dug Yeo Han; Philpott, Martin; Barclay, Murray L.; Gearry, Richard B.; McCulloch, Alan; Demmers, Pieter S.; Browning, Brian L. // BMC Research Notes;2009, Vol. 2, p1 

    Background: The nucleotide-binding oligomerization domain containing 1 (NOD1) gene encodes a pattern recognition receptor that senses pathogens, leading to downstream responses characteristic of innate immunity. We investigated the role of NOD1 single nucleotide polymorphisms (SNPs) on IBD risk...

  • Hydroxylases as therapeutic targets in inflammatory bowel disease. Cummins, Eoin P.; Doherty, Glen A.; Taylor, Cormac T. // Laboratory Investigation (00236837);Apr2013, Vol. 93 Issue 4, p378 

    Inflammatory bowel disease (IBD) is a common and debilitating clinical disorder comprising ulcerative colitis and Crohn disease. IBD occurs when inappropriate immunological activity in the intestinal mucosa results in epithelial barrier dysfunction leading to exposure of the mucosal immune...

  • Crohn’s disease in a Meckel’s diverticulum: report of a case. Diamond, Ivan R.; Hayes-Jordan, Andrea; Phillips, M. James; Langer, Jacob C. // Pediatric Surgery International;Mar2008, Vol. 24 Issue 3, p361 

    Meckel’s diverticulum has previously been reported to be present in patients with Crohn’s disease. However, the finding is typically an incidental one, and involvement of the diverticulum in the disease process is uncommon. We report a case of an adolescent with known...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics